Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing

The Relapsing-Remitting Multiple Sclerosis (MS) patients research has revealed that the matrix metalloproteinase-2 level in cerebrospinal fluid which is higher then 30 ng/ml during the relapse and/or remission period increases repeated relapse risk during 2 years term by 2.8 times. The rapid MS prog...

Full description

Saved in:
Bibliographic Details
Main Authors: I. V. Smagina, S. A. Yelchaninova, A. V. Popovtseva, Yu. N. Ignatova, A. O. Gridina, A. S. Fedyanin
Format: Article
Language:English
Published: Siberian State Medical University (Tomsk) 2010-08-01
Series:Бюллетень сибирской медицины
Subjects:
multiple sclerosis
cerebrospinal fluid
Online Access:https://bulletin.ssmu.ru/jour/article/view/1646
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items